Outlook Therapeutics Inc (OTLK) average volume reaches $1.64M: Is Wall Street expecting a rally?
On Friday, Outlook Therapeutics Inc (NASDAQ: OTLK) was 3.60% up from the session before settling in for the closing price of $1.39. A 52-week range
On Friday, Outlook Therapeutics Inc (NASDAQ: OTLK) was 3.60% up from the session before settling in for the closing price of $1.39. A 52-week range
A new trading day began on Monday, with Outlook Therapeutics Inc (NASDAQ: OTLK) stock price down -3.38% from the previous day of trading, before settling
Outlook Therapeutics Inc (NASDAQ: OTLK) open the trading on Thursday, with a bit cautious approach as it glided -1.91% to $1.54, before settling in for
On Monday, Outlook Therapeutics Inc (NASDAQ: OTLK) opened higher 11.84% from the last session, before settling in for the closing price of $1.52. Price fluctuations
Outlook Therapeutics Inc (NASDAQ: OTLK) started the day on Thursday, with a price decrease of -11.45% at $1.47, before settling in for the price of
Outlook Therapeutics Inc (NASDAQ: OTLK) kicked off on Monday, down -0.98% from the previous trading day, before settling in for the closing price of $2.05.
Witnessing the stock’s movement on the chart, on Wednesday, Outlook Therapeutics Inc (NASDAQ: OTLK) had a quiet start as it plunged -65.24% to $1.70, before
Outlook Therapeutics Inc (NASDAQ: OTLK) flaunted slowness of -4.87% at $5.27, before settling in for the price of $5.54 at the close. Taking a more
Outlook Therapeutics Inc (NASDAQ: OTLK) kicked off on Friday, up 3.31% from the previous trading day, before settling in for the closing price of $5.14.
After discovering a number of insider transactions, Outlook Therapeutics Inc. (NASDAQ: OTLK) shares rose 10.24% in after-hours trading to $1.40 at the last check. The
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.